Key result
hADMSC-sEVs improve grafted fat survival and volume vs control in mice by promoting neovascularization.
Why the study?
Small extracellular vesicles play a crucial role in the cellular microenvironment, prompting investigation into the characteristics of hADMSC-sEVs and their role in improving grafted fat survival.
Do hADMSC-sEVs improve the survival rate of grafted fat in nude mouse models?
Do hADMSC-sEVs improve the survival rate of grafted fat in nude mouse models?
p-value: p=<0.05
hADMSC-sEVs promote the survival of grafted fats by enhancing neovascularisation, highlighting their potential as a cell-free therapy in regenerative medicine.
sEVs from adipose stromal cells may enhance fat graft survival; leaves open clinical translation pending controlled human studies.
BACKGROUND: Small extracellular vesicles (sEVs) with genetic information secreted by cells play a crucial role in the cellular microenvironment. In this study, our purpose is to explore the characteristics of the small extracellular vesicles of human adipose-derived mesenchymal stromal cells (hADMSC-sEVs) and studied the role of hADMSC-sEVs in improving the survival rate of grafted fat. METHODS: In the present study, we used the transmission electron microscopy, nano-tracking analysis, nanoflow surface protein analysis, and zeta potential value to identify sEVs. SEVs' trajectory was traced dynamically to verify whether hADMSC-sEVs can be internalized into human umbilical vein endothelial cells (HUVECs) in vitro at different times. The angiogenic property of hADMSC-sEVs was observed by measuring the volume, weight, and histological analysis of the grafted fats in nude mouse models. RESULTS: Our research showed that the hADMSC-sEVs were sEVs with double-layer membrane structure and the diameter of which is within 30-150 nm. hADMSC-sEVs exert biological influence mainly through internalization into cells. Compared with the control group, the hADMSC-sEVs group had a significantly higher survival rate of grafted fat, morphological integrity, and a lower degree of inflammation and fibrosis. And immunohistochemistry showed that hADMSC-sEVs significantly increased the neovascularisation and the expression of CD34, VEGFR2, and Ki-67 in the graft tissue. CONCLUSIONS: As a potential nanomaterial, hADMSC-sEVs have been explored in the field of cell-free application of stem cell technology. hADMSC-sEVs promoted the survival of grafted fats by promoting the formation of new blood vessels, which is another promising progress in the field of regenerative medicine. We believe that hADMSC-sEVs will have a broad application prospect in the field of regenerative medicine in the future.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2021) studied Fat graft survival (n=18). hADMSC-sEVs vs. 0.1 ml PBS was evaluated on Graft survival rate (p=<0.05). hADMSC-sEVs significantly improved the survival rate, weight, and volume of grafted fat in a nude mouse model compared to control by promoting neovascularization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: